Literature DB >> 16957149

Oncogene-induced cell senescence--halting on the road to cancer.

W J Mooi1, D S Peeper.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16957149     DOI： 10.1056/NEJMra062285

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  149 in total

1.  Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis.

Authors:  Roel H Wilting; Eva Yanover; Marinus R Heideman; Heinz Jacobs; James Horner; Jaco van der Torre; Ronald A DePinho; Jan-Hermen Dannenberg
Journal:  EMBO J       Date:  2010-06-22       Impact factor: 11.598

2.  Survivin and escaping in therapy-induced cellular senescence.

Authors:  Qin Wang; Peter C Wu; Rachel S Roberson; Belinda V Luk; Iana Ivanova; Elizabeth Chu; Daniel Y Wu
Journal:  Int J Cancer       Date:  2010-05-25       Impact factor: 7.396

3.  Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis.

Authors:  Jung H Back; Yucui Zhu; Alyssa Calabro; Craig Queenan; Audrey S Kim; Joshua Arbesman; Arianna L Kim
Journal:  Photochem Photobiol       Date:  2012-02-17       Impact factor: 3.421

4.  Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models.

Authors:  Silvestre Vicent; Ron Chen; Leanne C Sayles; Chenwei Lin; Randal G Walker; Anna K Gillespie; Aravind Subramanian; Gregory Hinkle; Xiaoping Yang; Sakina Saif; David E Root; Vicki Huff; William C Hahn; E Alejandro Sweet-Cordero
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

5.  Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.

Authors:  Mona L Gauthier; Hal K Berman; Caroline Miller; Krystyna Kozakeiwicz; Karen Chew; Dan Moore; Joseph Rabban; Yunn Yi Chen; Karla Kerlikowske; Thea D Tlsty
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

6.  ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence.

Authors:  Linan Ha; Takeshi Ichikawa; Miriam Anver; Ross Dickins; Scott Lowe; Norman E Sharpless; Paul Krimpenfort; Ronald A Depinho; Dorothy C Bennett; Elena V Sviderskaya; Glenn Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

7.  Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.

Authors:  Olivier Bailet; Nina Fenouille; Patricia Abbe; Guillaume Robert; Stéphane Rocchi; Nadège Gonthier; Christophe Denoyelle; Michel Ticchioni; Jean-Paul Ortonne; Robert Ballotti; Marcel Deckert; Sophie Tartare-Deckert
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

8.  p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.

Authors:  Raya Saab; Carlos Rodriguez-Galindo; Kelly Matmati; Jerold E Rehg; Shannon H Baumer; Joseph D Khoury; Catherine Billups; Geoffrey Neale; Kathleen J Helton; Stephen X Skapek
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

9.  A prospective study of telomere length and the risk of skin cancer.

Authors:  Jiali Han; Abrar A Qureshi; Jennifer Prescott; Qun Guo; Li Ye; David J Hunter; Immaculata De Vivo
Journal:  J Invest Dermatol       Date:  2008-07-31       Impact factor: 8.551

10.  Significance of cellular senescence in aging and cancer.

Authors:  Angela Grimes; Sathees B C Chandra
Journal:  Cancer Res Treat       Date:  2009-12-31       Impact factor: 4.679
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.